Scarica l'app Stockscreener
1.40
0.00%
0.00
Dopo l'orario di chiusura:
1.36
-0.04
-2.86%
Precedente Chiudi:
$1.40
Aprire:
$1.42
Volume 24 ore:
39,471
Relative Volume:
0.70
Capitalizzazione di mercato:
$13.80M
Reddito:
-
Utile/perdita netta:
$-18.98M
Rapporto P/E:
-0.4906
EPS:
-2.8535
Flusso di cassa netto:
$-14.55M
1 W Prestazione:
+16.67%
1M Prestazione:
+27.27%
6M Prestazione:
-2.78%
1 anno Prestazione:
-38.86%
Intervallo 1D:
$1.3421
$1.46
Intervallo di 1 settimana:
$1.19
$1.46
Portata 52W:
$0.88
$2.73
In 8 Bio Inc Stock (INAB) Company Profile
Nome
In 8 Bio Inc
Settore
Industria
Telefono
(646) 600-6438
Indirizzo
EMPIRE STATE BUILDING, NEW YORK
Compare INAB vs VRTX, MRNA, REGN, ARGX, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
INAB
In 8 Bio Inc
|
1.40 | 11.83M | 0 | -18.98M | -14.55M | -2.8535 |
VRTX
Vertex Pharmaceuticals Inc
|
504.73 | 133.37B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
190.01 | 79.40B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
735.20 | 81.13B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
919.21 | 60.03B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
206.64 | 43.93B | 742.00K | -1.37B | -1.07B | -7.0731 |
In 8 Bio Inc Stock (INAB) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-03-18 | Iniziato | Laidlaw | Buy |
| 2022-08-30 | Iniziato | H.C. Wainwright | Buy |
In 8 Bio Inc Borsa (INAB) Ultime notizie
Valion Bio Announces Completion of Entolimod Oral Mucosal Formulation Development - kalkinemedia.com
Doctors will present 24-month results from a teen eye-disease trial in New Orleans. - Stock Titan
After 16 weeks off treatment, Q32 Bio (QTTB) reports results from its 33-patient hair-loss trial. - Stock Titan
A shareholder falls below 5% in Gossamer Bio (GOSS) after a reverse stock split. - Stock Titan
GRI Bio, Inc. SEC Filing (Sep 28, 2026) - Stock Titan
Gossamer Bio regains Nasdaq compliance after 1-for-80 reverse stock split - TradingView
Q32 Bio Inc. (QTTB) Stock Price | Live Quotes & Charts | NASDAQ - timothysykes.com
Data on a possible lupus treatment are due Monday - Stock Titan
After a 1-for-25 reverse stock split, Valion Bio (VBIO) executive reports a stock-unit settlement. - stocktitan.net
Stocks in play: Avai Bio Inc - The Globe and Mail
IN8bio to Present at Sidoti Small-Cap Virtual Conference - GlobeNewswire Inc.
TELA Bio Received Notice of Delisting - TradingView
Upstream Bio (UPB) exec offloads shares to cover taxes - Stock Titan
Inmune Bio (NASDAQ: INMB) grants 100,000 stock options to new director - Stock Titan
$2.50 share warrants bring new cash to Cabaletta Bio (CABA) - Stock Titan
700,000 face alopecia as Q32 Bio (QTTB) hires drug veterans - Stock Titan
Kala Bio Secures 5-Year Exclusive U.S. Distribution for Ophthalmic Genetic Testing With Virotek - tradingview.com
Senior finance VP at Korro Bio (KRRO) sells 7,353 shares under 10b5-1 trading plan - Stock Titan
Kyntra Bio (KYNB) CFO holds 4,355 shares after tax withholding - Stock Titan
KALA BIO (NASDAQ: KALA) sets Sept. 19 cutoff for 2026 shareholder proposals - Stock Titan
Braveheart Bio Completes IPO with $122.8 Million in Gross Proceeds - Minichart
Adicet Bio posts September 2026 investor presentation outlining prula-cel and ADI-212 clinical timelines - TradingView
Braveheart Bio (NASDAQ:BRVE) Trading Up 8%Should You Buy? - MarketBeat
PeproMene Bio Announces Publication in The Lancet of Breakthrough Phase 1 Clinical Trial Results Demonstrating Deep and Durable Complete Responses in Relapsed/Refractory B-cell Lymphomas, including after prior CD19 CAR T-cell failure - BioSpace
GRI Bio posts Phase 2a IPF biomarker and safety data; +99 mL placebo‑adj FVC, supports longer study - TradingView
Experimental IPF pill from GRI Bio (GRI) boosts lung function in 12 weeks as company eyes 52-week study - stocktitan.net
Cough during treatment was 0% with GRI Bio's drug, versus 25% on placebo - stocktitan.net
symbol__ Stock Quote Price and Forecast - CNN
Investor group in Valion Bio (VBIO) shifts to passive stake - Stock Titan
[425] Passage BIO, Inc. Business Combination Communication | PASG SEC FilingForm 425 - Stock Titan
Valion Bio Raises $7.74 Million Via Series B/C Preferred and Warrants From 3i - TradingView
2,426,857 Boundless Bio (NASDAQ: BOLD) shares held by Zachary Hornby - stocktitan.net
KALA BIO Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
FDA clears Adicet Bio's application to study a gene-edited prostate cancer therapy - Stock Titan
Gossamer Bio (NASDAQ: GOSS) links CEO options to FDA decision on seralutinib - Stock Titan
Valion Bio, Inc. SEC Filing (Aug 24, 2026) - Stock Titan
Gossamer Bio (NASDAQ: GOSS) has 6% of its stock under D. E. Shaw’s reported influence - Stock Titan
TBIO | TELESIS BIO INC Insider Trading - Quiver Quantitative
Gossamer Bio Lines Up Up To $250 Million Private Placement With Milestone-Triggered Warrants - TradingView
3i injects cash into Valion Bio (VBIO) under tight ownership cap - Stock Titan
Climb Bio Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
Tech workers may be better off selling their company stock - Business Insider
TELA Bio (TELA) stake: Nantahala group reports 12.94% ownership of 5.79M shares - Stock Titan
Palisade Bio (PALI): Commodore Capital group now reports 0.0% beneficial ownership - Stock Titan
Climb Bio, Inc. (CLYM): MPM BioImpact LLC reports 0% ownership in amendment - Stock Titan
Point72 discloses 4.95% Q32 Bio Inc. (QTTB) holding in Schedule 13G/A - Stock Titan
Highbridge Capital (ANVS) discloses 6.1% Annovis Bio stake tied to 2.78M warrant shares - Stock Titan
Cabaletta Bio (CABA): T. Rowe Price reports 11.6% common stock stake - Stock Titan
Q32 Bio Inc. (QTTB) major holders cut reported stake to 0% - Stock Titan
Caballeta Bio (CABA) stake: Bain Capital Life Sciences reports 9.99% position - Stock Titan
Korro Bio (KRRO) director-affiliated funds sell 2,143 shares under 10b5-1 plan - Stock Titan
In 8 Bio Inc Azioni (INAB) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.05%
0.82%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):